Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$513,960,857
+$89,811,208 QoQ
Shares Held
2,042,445
+4.7% QoQ
Ownership
0.116%
of shares outstanding
% of Portfolio
0.95%
of 13F equity value
Holder Rank
#80
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Baird Financial Group, Inc. holds $2,528,024,463 across 14 Drug Manufacturers - General names. ABBV ranks #2 (20.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,799,159 | $1,218,842,409 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
2,042,445 | $513,960,857 | |
| 3 | LLY |
ELI LILLY & Co
|
303,814 | $364,403,654 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,064,683 | $136,811,765 | |
| 5 | AMGN |
Amgen Inc
|
339,825 | $123,057,427 | |
| 6 | PFE |
Pfizer Inc
|
2,312,826 | $55,692,848 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
292,295 | $36,928,549 | |
| 8 | AZN |
Astrazeneca PLC
|
134,149 | $25,437,332 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $513,960,857 | 2,042,445 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $424,149,649 | 1,950,203 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $450,898,736 | 1,973,385 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $462,033,669 | 1,995,481 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $368,890,049 | 1,987,340 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $423,972,519 | 2,023,542 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $369,721,730 | 2,080,595 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $417,125,549 | 2,112,242 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $365,442,398 | 2,130,611 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $392,882,388 | 2,157,509 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $324,765,514 | 2,095,667 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $310,533,417 | 2,083,278 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $285,679,739 | 2,120,387 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $380,001,826 | 2,384,400 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $381,501,736 | 2,360,632 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $375,745,991 | 2,799,687 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $481,561,534 | 3,144,173 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $526,366,468 | 3,246,971 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $435,105,056 | 3,213,479 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $344,170,344 | 3,190,603 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $356,955,370 | 3,168,993 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $341,657,573 | 3,157,065 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $334,713,990 | 3,123,789 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $266,491,172 | 3,042,484 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $303,282,927 | 3,089,050 | Shares | Defined | 2020-10-22 | |
| 2020-03-31 | $220,615,153 | 2,895,592 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||